Helix Selects Swift Biosciences to Power Exome+™ Assay with Swift 2S™ Turbo DNA Library System

Swift Biosciences, Inc (“Swift”) and Helix OpCo, LLC (“Helix”) today announced a Partnership Agreement to leverage Swift’s 2S Turbo DNA library preparation for Helix’s Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health programs focused on accelerating the integration of genomics into clinical care and facilitating novel genetic discovery.